Hormone replacement therapy as treatment of breast cancer--a phase II study of Org OD 14 (tibilone).

Org OD 14 (tibilone) is a synthetic steroid, designed to combine the favourable effects of oestrogens, progestagens and androgens into a single substance for use as hormone replacement therapy (HRT). Given its antiovulatory properties, the ability to control menopausal symptoms and blocking action o...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Brien, M., Montes, A., Powles, T. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074401/
https://www.ncbi.nlm.nih.gov/pubmed/8624268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074401/
https://www.ncbi.nlm.nih.gov/pubmed/8624268

Ejemplares similares